Human Reproduction Update Advance Access originally published online on October 22, 2008
Human Reproduction Update 2009 15(1):139-151; doi:10.1093/humupd/dmn047
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis
PHG Foundation Strangeways Research Laboratory, 2 Worts Causeway, Cambridge CB1 8RN, UK
1 Correspondence address. Tel: +44-1223-740200; Fax: +44-1223-740892; E-mail: caroline.wright{at}phgfoundation.org
BACKGROUND: Cell-free fetal nucleic acids (cffNA) can be detected in the maternal circulation during pregnancy, potentially offering an excellent method for early non-invasive prenatal diagnosis (NIPD) of the genetic status of a fetus. Using molecular techniques, fetal DNA and RNA can be detected from 5 weeks gestation and are rapidly cleared from the circulation following birth.
METHODS: We searched PubMed systematically using keywords free fetal DNA and NIPD. Reference lists from relevant papers were also searched to ensure comprehensive coverage of the area.
RESULTS: Cell-free fetal DNA comprises only 3–6% of the total circulating cell-free DNA, therefore diagnoses are primarily limited to those caused by paternally inherited sequences as well as conditions that can be inferred by the unique gene expression patterns in the fetus and placenta. Broadly, the potential applications of this technology fall into two categories: first, high genetic risk families with inheritable monogenic diseases, including sex determination in cases at risk of X-linked diseases and detection of specific paternally inherited single gene disorders; and second, routine antenatal care offered to all pregnant women, including prenatal screening/diagnosis for aneuploidy, particularly Down syndrome (DS), and diagnosis of Rhesus factor status in RhD negative women. Already sex determination and Rhesus factor diagnosis are nearing translation into clinical practice for high-risk individuals.
CONCLUSIONS: The analysis of cffNA may allow NIPD for a variety of genetic conditions and may in future form part of national antenatal screening programmes for DS and other common genetic disorders.
Key words: cell-free fetal DNA (cffDNA) / non-invasive prenatal diagnosis (NIPD) / cell-free fetal nucleic acids / prenatal diagnosis / genetic diagnosis
Received on June 26, 2008; revised September 15, 2008; accepted on September 25, 2008
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Huang, H. Li, X. Ding, and C. Xiong Presence and Characterization of Cell-Free Seminal RNA in Healthy Individuals: Implications for Noninvasive Disease Diagnosis and Gene Expression Studies of the Male Reproductive System Clin. Chem., November 1, 2009; 55(11): 1967 - 1976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F Wright and L. S Chitty Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing BMJ, July 6, 2009; 339(jul06_2): b2451 - b2451. [Full Text]
|
|